311 related articles for article (PubMed ID: 29916116)
1. Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.
Huo Y; Kang L; Pang X; Shen H; Yan P; Zhang C; Liao X; Chen X; Wang R
Mol Imaging Biol; 2019 Apr; 21(2):286-296. PubMed ID: 29916116
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of
Cai H; Li Z; Shi Q; Yang H; Xiao L; Li M; Lin H; Wu X; She T; Chen L; Li L; Lu X
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2952-2961. PubMed ID: 37256321
[TBL] [Abstract][Full Text] [Related]
5. A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model.
Kim MH; Kim SG; Kim DW
J Labelled Comp Radiopharm; 2018 Jun; 61(7):557-566. PubMed ID: 29603784
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of gallium-68-labeled nitroimidazole-based imaging probes for PET diagnosis of tumor hypoxia.
Shimizu Y; Nakai Y; Iikuni S; Watanabe H; Nakamoto Y; Ono M
Ann Nucl Med; 2021 Mar; 35(3):360-369. PubMed ID: 33423155
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
[TBL] [Abstract][Full Text] [Related]
8. A novel 99mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot study.
Zhao Q; Yan P; Wang RF; Zhang CL; Li L; Yin L
PLoS One; 2013; 8(4):e61043. PubMed ID: 23573294
[TBL] [Abstract][Full Text] [Related]
9. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Ujula T; Huttunen M; Luoto P; Peräkylä H; Simpura I; Wilson I; Bergman M; Roivainen A
Bioconjug Chem; 2010 Sep; 21(9):1612-21. PubMed ID: 20795647
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.
Xu J; Cai F; Luo Z; Fan W; Dai J; Cui J; Li S; Geng C; Zheng Q; Wang Z; Tang X
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2618-2633. PubMed ID: 35347438
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
[TBL] [Abstract][Full Text] [Related]
16. Tumor Targeting via Sialic Acid: [
Tsoukalas C; Geninatti-Crich S; Gaitanis A; Tsotakos T; Paravatou-Petsotas M; Aime S; Jiménez-Juárez R; Anagnostopoulos CD; Djanashvili K; Bouziotis P
Mol Imaging Biol; 2018 Oct; 20(5):798-807. PubMed ID: 29464496
[TBL] [Abstract][Full Text] [Related]
17. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
18. Effect of Macro-Cyclic Bifunctional Chelators DOTA and NODAGA on Radiolabeling and
Vatsa R; Shukla J; Kumar S; Chakraboarty S; Dash A; Singh G; Mittal BR
Cancer Biother Radiopharm; 2019 Sep; 34(7):427-435. PubMed ID: 31112044
[No Abstract] [Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of
Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of Tc-99m-labeled RRL-containing peptide as a non-invasive tumor imaging agent in a mouse fibrosarcoma model.
Kim DW; Kim WH; Kim MH; Kim CG
Ann Nucl Med; 2015 Nov; 29(9):779-85. PubMed ID: 26179963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]